Finance

Lists
Why is JSPR up ၄.၈၈%?
Dive Deeper
JSPR:NASDAQ
Jasper Therapeutics Inc
၀.၅၉ US$
+၄.၈၈%
(+၀.၀၂၈) 1D
၀.၅၉ US$
+၀.၁၇% (+၀.၀၀၁၀၀)
After hours
Closed: အောက် ၅, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Open
၀.၅၇ US$
High
၀.၆၀ US$
Low
၀.၅၄ US$
Mkt. cap
၁.၉၆ ကုဋေ
Avg. vol.
၃.၇၂ သိန်း
Volume
၀.၀၀
52-wk high
၂.၆၉ US$
52-wk low
၀.၃၂ US$
EPS
-၁.၅၈ US$
Beta
၃.၁၆
Shares outstanding
၃.၃၃ ကုဋေ
No. of employees
၂၂
Open
၀.၅၇ US$
High
၀.၆၀ US$
Low
၀.၅၄ US$
Mkt. cap
၁.၉၆ ကုဋေ
Avg. vol.
၃.၇၂ သိန်း
Volume
၀.၀၀
52-wk high
၂.၆၉ US$
52-wk low
၀.၃၂ US$
EPS
-၁.၅၈ US$
Beta
၃.၁၆
Shares outstanding
၃.၃၃ ကုဋေ
No. of employees
၂၂
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၄ နာရီ
Jasper Therapeutics approves reverse split for Jasper Therapeutics stock
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Jasper Therapeutics Stockholders Approve Capital Structure Flexibility
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၃ ရက်
After closing roughly $132M in financing, Jasper Therapeutics (JSPR) reports illustrative combined losses.
About Jasper Therapeutics Inc
CEO-
Employees၂၂
Founded၂၀၁၈
HeadquartersRedwood City, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitejaspertx.com
Analyst ratings
Based on 2 analysts giving stock ratings to JSPR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current ၀.၅၉ US$
၂၀.၀၀ US$ (+၃,၂၇၃.၈၂%)
Average
၁၁.၀၀ US$ (+၁,၇၅၅.၆၀%)
Lowest
၂.၀၀ US$ (+၂၃၇.၃၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
၂၀.၀၀ US$
+၃,၂၇၃.၈%
09/21/2026
Biren Amin
Piper Sandler
Buy
Initiated
၂.၀၀ US$
+၂၃၇.၄%
08/12/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
06/01/2026
Leonid Timashev
RBC Capital
Hold
Maintained
၃.၀၀ US$
+၄၀၆.၁%
05/14/2026
Yaron Werber
TD Cowen
Hold
Downgraded
-
-
05/15/2026
David Dai
UBS
Hold
Maintained
၁.၅၀ US$
+၁၅၃%
04/02/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
၇.၀၀ US$
+၁,၀၈၀.၈%
04/01/2026
Michael King
Rodman & Renshaw
Buy
Initiated
၁၇.၀၀ US$
+၂,၇၆၇.၇%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၃၁ ကုဋေ
၁.၀၉ ကုဋေ
၅.၈၁ သန်း
၅.၁၄ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၂၆ သန်း
၄.၄၉ သန်း
၅.၁၄ သန်း
၄.၀၇ သန်း
Operating expense
၁.၇၄ ကုဋေ
၁.၅၃ ကုဋေ
၁.၁၀ ကုဋေ
၉.၂၁ သန်း
Total operating expenses
၁.၇၄ ကုဋေ
၁.၅၃ ကုဋေ
၁.၁၀ ကုဋေ
၉.၂၁ သန်း
Operating income
-၁.၇၄ ကုဋေ
-၁.၅၃ ကုဋေ
-၁.၁၀ ကုဋေ
-၉.၂၁ သန်း
Other non operating income
၈.၈၀ သောင်း
၆.၄၀ သန်း
၉.၆၁ သန်း
၆.၃၆ သန်း
EBT including unusual items
-၁.၈၇ ကုဋေ
-၉.၁၀ သန်း
-၁.၁၇ သန်း
-၂.၇၆ သန်း
EBT excluding unusual items
-၁.၆၉ ကုဋေ
-၈.၆၁ သန်း
-၁.၁၇ သန်း
-၂.၇၆ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၈၇ ကုဋေ
-၉.၁၀ သန်း
-၁.၁၇ သန်း
-၂.၇၆ သန်း
Net profit margin
-
-
-
-
Earnings per share
-၁.၂၅
-၀.၅၄
-၀.၃၈
-၀.၂၃
Interest and investment income
၃.၄၂ သိန်း
၃.၃၈ သိန်း
၁.၆၄ သိန်း
၈.၂၀ သောင်း
Interest expense
-
-
-
-
Net interest expenses
၃.၄၂ သိန်း
၃.၃၈ သိန်း
၁.၆၄ သိန်း
၈.၂၀ သောင်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၇၁ ကုဋေ
-၁.၅၁ ကုဋေ
-၁.၀၉ ကုဋေ
-၉.၁၉ သန်း
Gain or loss from assets sale
-၂.၀၀ ထောင်
-
-
-၈.၀၀ သောင်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ